Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

[1]  P. Serruys,et al.  Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial , 2021, The Lancet.

[2]  P. Serruys,et al.  Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study , 2021, European heart journal.

[3]  E. Hess,et al.  2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Journal of the American College of Cardiology.

[4]  J. Escaned,et al.  Coronary microcirculation assessment using functional angiography: Development of a wire‐free method applicable to conventional coronary angiograms , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  Kirsty L Moreton.  A Backwards-step for Gillick: Trans Children's Inability to Consent to Treatment for Gender Dysphoria-Quincy Bell & Mrs A v The Tavistock and Portman NHS Foundation Trust and Ors [2020] EWHC 3274 (Admin). , 2021, Medical law review.

[6]  P. Serruys,et al.  Trade-Off Between Bleeding and Thrombotic Risk in Patients With Academic Research Consortium for High Bleeding Risk. , 2021, JAMA cardiology.

[7]  A. Barakat,et al.  eG Coated Stents Exhibit Enhanced Endothelial Wound Healing Characteristics , 2021, Cardiovascular Engineering and Technology.

[8]  W. Wijns,et al.  Revascularization decisions in patients with chronic coronary syndromes: Results of the second international survey on interventional strategy (ISIS-2). , 2021, International journal of cardiology.

[9]  S. Saito,et al.  Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease , 2021 .

[10]  S. Pocock,et al.  Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. , 2021, JAMA cardiology.

[11]  P. Serruys,et al.  Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study. , 2020, JACC. Cardiovascular interventions.

[12]  Deepak L. Bhatt,et al.  Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome , 2020, Circulation.

[13]  Deepak L. Bhatt,et al.  2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.

[14]  R. Virmani,et al.  Comparison of endothelial barrier functional recovery after implantation of a novel biodegradable polymer sirolimus-eluting stent in comparison to durable and biodegradable polymer everolimus-eluting stents. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[15]  Manesh R. Patel,et al.  The Impact of Coronary Physiology on Contemporary Clinical Decision Making. , 2020, JACC. Cardiovascular interventions.

[16]  G. Lip,et al.  CHOICES IN ANTITHROMBOTIC MANAGEMENT FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. QUESTIONS (AND ANSWERS) IN CHRONOLOGICAL SEQUENCE. , 2020, European heart journal. Cardiovascular pharmacotherapy.

[17]  M. Hlatky,et al.  Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease. , 2020, Journal of the American College of Cardiology.

[18]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[19]  G. Campo,et al.  Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient‐data meta‐analysis , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  T. Thim,et al.  Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST‐segment elevation myocardial infarction—An iSTEMI substudy , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  G. Campo,et al.  Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. , 2019, JACC. Cardiovascular interventions.

[22]  J. Reiber,et al.  Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease. , 2019, JACC. Cardiovascular interventions.

[23]  N. Hagiwara,et al.  Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. , 2019, The New England journal of medicine.

[24]  Deepak L. Bhatt,et al.  Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. , 2019, JAMA cardiology.

[25]  H. Okayama,et al.  Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. , 2019, JAMA.

[26]  A. Parkhomenko,et al.  Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation , 2019, The New England journal of medicine.

[27]  J. Reiber,et al.  Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease. , 2018, JACC. Cardiovascular interventions.

[28]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[29]  P. Serruys,et al.  Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial. , 2017, JACC. Cardiovascular interventions.

[30]  P. Serruys,et al.  Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[31]  P. Serruys,et al.  A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[33]  Jeroen J. Bax,et al.  Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis , 2018, European heart journal.

[34]  A. Jeremias,et al.  Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes. , 2018, JACC. Cardiovascular interventions.

[35]  H. Bøtker,et al.  Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve: The FAVOR II Europe‐Japan Study , 2018, Journal of the American Heart Association.

[36]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, Circulation.

[37]  J. Spertus,et al.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document , 2018, European heart journal.

[38]  B. Koo,et al.  Coronary Psychology: Do You Believe? , 2018, JACC. Cardiovascular interventions.

[39]  P. Jüni,et al.  Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve , 2018, The New England journal of medicine.

[40]  P. Serruys,et al.  Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. , 2018, JACC. Cardiovascular interventions.

[41]  C. Macaya,et al.  Influence of Microcirculatory Dysfunction on Angiography-Based Functional Assessment of Coronary Stenoses. , 2018, JACC. Cardiovascular interventions.

[42]  Emil N. Holck,et al.  Evaluation of Coronary Artery Stenosis by Quantitative Flow Ratio During Invasive Coronary Angiography , 2018, Circulation. Cardiovascular imaging.

[43]  Shengshou Hu,et al.  Angiography-Based Quantitative Flow Ratio for Online Assessment of Coronary Stenosis : FAVOR II China Study , 2017 .

[44]  Deepak L. Bhatt,et al.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation , 2017, The New England journal of medicine.

[45]  G. Rioufol,et al.  Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation , 2017, Circulation. Cardiovascular interventions.

[46]  Jun-Jie Zhang,et al.  Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study. , 2017, JACC. Cardiovascular interventions.

[47]  E. Omerovic,et al.  Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI , 2017, The New England journal of medicine.

[48]  A. Jeremias,et al.  Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI , 2017, The New England journal of medicine.

[49]  B. De Bruyne,et al.  Clinical value of post–percutaneous coronary intervention fractional flow reserve value: A systematic review and meta‐analysis , 2017, American heart journal.

[50]  HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography , 2017 .

[51]  G. Lip,et al.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. , 2016, The New England journal of medicine.

[52]  J. Reiber,et al.  Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study. , 2016, JACC. Cardiovascular interventions.

[53]  B. Uretsky,et al.  Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. , 2016, JACC. Cardiovascular interventions.

[54]  P. Stella,et al.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. , 2015, European heart journal.

[55]  J. Reiber,et al.  Image-based assessment of fractional flow reserve. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[56]  C. V. van Mieghem,et al.  Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions: Results of the International Survey on Interventional Strategy , 2014, Circulation. Cardiovascular interventions.

[57]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.

[58]  William Wijns,et al.  Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count: a fast computer model to quantify the functional significance of moderately obstructed coronary arteries. , 2014, JACC. Cardiovascular interventions.

[59]  M. Mack,et al.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). , 2013, Journal of the American College of Cardiology.

[60]  Tom Adriaenssens,et al.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[61]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[62]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[63]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[64]  William Wijns,et al.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.